MHIP

AS OF

Sep 18, 11:39 AM (EDT)

Price

$20.77

Change

+$0.15 (+0.73%)

Net Assets

1.56M

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

+Compare

MHIP

ETF ticker: NYSE ARCA

AS OF

Sep 18, 11:39 AM (EDT)

Price

$20.77

Change

+$0.15 (+0.73%)

Net Assets

1.56M

MHIP

ETF ticker: NYSE ARCA

PRICE

CHANGE

NET ASSETS

MHIP stock forecast, quote, news & analysis

Category: #Health

Get AI intraday signals

MHIP

Setup

Daily Signal:

Description

Gain/Loss:

A.I.Advisor

published price charts

View AI-Driven Trading for MHIP

Interact to see
Advertisement

A.I.Advisor

a Summary for MHIP with price predictions

Sep 23, 2026

Momentum Indicator for MHIP turns negative, indicating new downward trend

MHIP saw its Momentum Indicator move below the 0 level on September 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 5 similar instances where the indicator turned negative. In 1 of the 5 cases, the stock moved further down in the following days. The odds of a decline are at 20%.

Technical Analysis (Indicators)

Bearish Trend Analysis

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

A.I.Advisor

published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to generate returns (before Fund fees and expenses) that over time exceed the healthcare costs for an individual utilizing an employer-provided health plan in the United States (“U.S. Healthcare Cost Inflation”). The common stocks in which the fund primarily invests are those issued by companies in the U.S. healthcare sector and sectors that comprise the supply chain for the U.S. healthcare sector, and include companies of all capitalization sizes. Milliman determines the common stock portfolio weight by implementing a factor approach. The fund is non-diversified.

Market Cap

The average market capitalization across the Milliman Healthcare Inflation Plus ETF (MHIP) ETF is 128.55B. The market cap for tickers in the group ranges from 9.15B to 1.03T. LLY holds the highest valuation in this group at 1.03T. The lowest valued company is CYTK at 9.15B.

High and low price notable news

The average weekly price growth across all stocks in the Milliman Healthcare Inflation Plus ETF (MHIP) ETF was 23%. For the same ETF, the average monthly price growth was 23%, and the average quarterly price growth was 293%. MRNA experienced the highest price growth at 25%, while AXSM experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Milliman Healthcare Inflation Plus ETF (MHIP) ETF was 8%. For the same stocks of the ETF, the average monthly volume growth was 15% and the average quarterly volume growth was -8%